| # | % | |||||
|---|---|---|---|---|---|---|
| 201 | ISHARES GOLD TRUST | 12,365 | 158,000 | 0.01% | ||
| 202 | CTI BIOPHARMA | 410,616 | 140,000 | 0.01% | ||
| 203 | TRANSDIGM GROUP INC | 385 | 102,000 | 0.01% | ||
| 204 | CORMEDIX INCORPORATED | 24,750 | 49,000 | 0.00% | ||
| 205 | AKAMAI TECHNOLOGIES INC | 563 | 31,000 | 0.00% | ||
| 206 | WRIGHT MED GROUP N V | 13,941 | 18,000 | 0.00% | ||
| 207 | REALOGY HLDGS CORP | 70 | 2,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001079736-16-000008, filed 2016.08.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.